Skip to main content
AACE 2024 Annual Meeting Main banner
Back

Rifka C. Schulman-Rosenbaum, MD, FACE, FACP (she/her/hers)

Professor of Medicine, Director of Inpatient Diabetes
Long Island Jewish Medical Center, Northwell Health
New Hyde Park, New York, United States

Rifka Schulman-Rosenbaum, MD, FACE, FACP is the Director of Inpatient Diabetes at Long Island Jewish (LIJ) Medical Center, Northwell Health in New Hyde Park, NY, and a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell.
Dr. Schulman-Rosenbaum specializes in management of inpatient diabetes and inpatient endocrinology. For more than a decade she has run a busy inpatient endocrine service full time, including supervision of a multidisciplinary diabetes team as well as endocrine fellows and other trainees. Under her leadership LIJ Medical Center has maintained certification with the Joint Commission for Advanced Inpatient Diabetes since 2014. Dr. Schulman-Rosenbaum participates in or leads numerous hospital committees and workgroups. Her research focuses on areas relating to inpatient diabetes, including SGLT2i management, hyperglycemia due to COVID-19 and Diabetes intervention in the emergency department. She was the recipient of The Salzman Award for Excellence in Quality for Northwell Health in 2019, Northwell Health Teacher of the Year for 2023 and the 2024 Patients’ Choice Award.
Dr. Schulman-Rosenbaum is the Vice Chair for the 2024 American Association of Clinical Endocrinology (AACE) annual meeting and recently served as the 2022-2023 Chair of the Diabetes Disease State Network for AACE. She is the editor of a newly published book entitled “Diabetes Management in Hospitalized Patients: A Comprehensive Clinical Guide.” Dr. Schulman-Rosenbaum also recently served as Chair for the Adult sub-group on an international guidance document to formalize monitoring of antibody positive, pre-stage 3 type 1 diabetes.

Disclosure information not submitted.

Presentation(s):